RaySearch and Varian Medical Systems expand strategic collaboration

RaySearch and Varian Medical Systems expand strategic collaboration

RaySearch Laboratories AB (publ) announces today that the license agreement with
Varian Medical Systems has been restructured to add one new product, strengthen
the collaborative product development efforts, and make it easier to add new
capabilities and features to Varian's Eclipse™ treatment planning system.
Eclipse software currently incorporates three RaySearch developments, including
tools for biological evaluation, biological optimization, and conformal
optimization.

“Varian is an innovative partner and also the leader in the radiation therapy
industry, so it is of great importance to RaySearch that we continue to
strengthen our collaboration. Extending the partnership to include more
development is a very positive step forward,” said Johan Löf, CEO of RaySearch. 
“We are proud to contribute toward the continued success of Eclipse.”

“This agreement reaffirms our commitment to this partnership. We are very
pleased with the RaySearch technologies already integrated with Eclipse, and are
eager to work with them to rapidly bring additional planning capabilities to our
customers,” said Jeff Amacker, director of clinical solutions for Varian.


FOR FURTHER INFORMATION, CONTACT:
Johan Löf, President and CEO
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com


ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are mainly sold through license agreements with leading partners such
as Philips, Varian, Siemens, Nucletron, IBA Dosimetry and TomoTherapy. To date,
15 products have been launched and RaySearch's software is used at some 1,500
clinics in more than 30 countries. In addition, existing license agreements
cover more than 15 other products that are scheduled to be launched in the
coming years. RaySearch was founded in 2000 as a spin-off from Karolinska
Institutet in Stockholm and the company is listed in the Small Cap segment on
NASDAQ OMX Stockholm. 

For more information about RaySearch, visit www.raysearchlabs.com.